This is the online version of STAT’s email newsletter Health Care Inc, delivered to your inbox...
Author - David Miller
Small Change: FDA’s Final Predetermined Change Control Plan...
By Lisa M. Baumhardt, Principal Medical Device Regulatory Expert — FDA recently released its...
Gilead Treatment for PBC Granted EC Conditional Marketing...
Seladelpar, which is marketed in the US as Livdelzi, was recommended for an orphan drug designation...
Pharma Pulse 2/24/25: Enhancing Pharma Supply Chain Transparency...
The latest news for pharma industry insiders.
How Technology is Impacting Launch Strategy Timelines
John Arena, interim president of global pharma services at Cencora, discusses how new technologies...
STAT+: J&J sues Samsung over a contract breach for a...
As biosimilar versions of a big-selling Johnson & Johnson medicine reach the U.S. market, the...
Powering Clinical Operations With Knowledge Graphs and LLMs With...
Webinar Date/Time: Thu, Mar 13, 2025 11:00 AM EDT
Boehringer Ingelheim Launches Trivalent Vaccine for H5 Avian...
Launching this month, Vaxitek HVT+IBD+H5 integrates COBRA technology to address the ongoing viral...
Pharma Pulse 2/25/25: Industry Leaders Share Top Trends in...
The latest news for pharma industry insiders.
FDA Approves Medtronic’s BrainSense Adaptive Deep Brain...
The BrainSense adaptive deep brain stimulation system personalizes therapy by dynamically adjusting...